Fig. 1From: Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cellsPromoter CpG islands (a) and VEGF, FLT1, and KDR pyrosequencing in 2 RCC lines (b). Closed bars, exon 1 region for each gene; arrows, translation start site; open bars, the region targeted for pyrosequencing; black segments within open bars, locations of sequencing primers for each geneBack to article page